Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000231296 (also known as RP1-39G22.4) is a pseudogene that shows sequence similarity to a portion of the RIO kinase 2 (RIOK2) gene found in yeast and humans[1]. Pseudogenes are generally defined as gene-like DNA sequences that no longer produce a functional protein product because of disabling mutations. They arise by duplication or retrotransposition from functional genes, and many have no known biological function. Some pseudogenes can be transcribed to RNA and might be involved in gene regulation at the RNA level, but most are not therapeutically targeted or directly involved in disease[2][4][6]. There is no evidence that ENSG00000231296 encodes a functional protein, is a drug target, or acts as a biomarker. Its annotation as a "pseudogene similar to part of RIO kinase 2" means it is not the functionally relevant kinase RIOK2, which itself is a ribosome biogenesis factor and potential cancer target, but is instead a nonfunctional relic that may be useful for comparative genomics or evolutionary studies[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of RIO kinase 2.